Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Meditology Services and CloudPost Networks Introduce Healthcare's First End-to-end Medical Device Security Solution


ATLANTA, Aug. 21, 2018 /PRNewswire/ -- Meditology Services, a leading healthcare information security services firm, has partnered with CloudPost Networks to provide the industry's first comprehensive end-to-end medical device security program solution. The innovative approach establishes a blueprint for medical device security programs that incorporates industry leading medical device inventory and protection software from CloudPost, and expert managed services to protect patients from security risks associated with medical devices.

Many healthcare entities struggle to identify which medical devices are active or may pose higher risks for an information breach due to improperly secured devices. Limited staff resources further impact the ability to properly manage device security.

"Medical devices have become the weakest link in the security chain," said Brian Selfridge, Partner, Meditology Services, LLC.  "We are excited to leverage the power of CloudPost's cutting-edge technology alongside Meditology's deep experience implementing medical device security strategies to keep patients safe from the daily onslaught of security threats." CloudPost's passive inventory discovery, behavioral and network analysis, and threat detection capabilities allow automation of security protections for thousands of medical devices. Meditology leverages this technology to implement a strategic plan defining the people and processes required to protect medical devices. A team of experts are deployed as a managed service to better protect healthcare's life-saving devices and systems."

"Healthcare entities struggling to get a handle on security protections for networked devices will greatly benefit from this partnership," said Gnanaprakasam Pandian, CEO and Co-Founder at CloudPost Networks.  "With combined expertise of Meditology's service practice and automation provided by CloudPost's software, greater security protection can be a reality for patients served by networked medical devices."

About Meditology Services

Meditology Services is an industry-leading advisory services firm dedicated to healthcare. Meditology provides consulting and management services to many of the largest healthcare organizations in the nation, assessing and developing security, privacy, and compliance programs. We advise the federal government including OCR, HHS, and ONC on medical device security and other security and compliance matters. To learn more about Meditology Services, visit www.meditologyservices.com and follow us on LinkedIn.

About CloudPost Networks

CloudPost Networks develops IoT security and risk-reduction solutions that protect business-critical devices and systems. CloudPost uniquely ties device identity with behavioral analytics so organizations can quickly spot security issues and implement precise controls to protect the environment. For more information, visit: www.cloudpostnetworks.com

­MEDIA CONTACT
Stephanie Attaway
(732) 768-0593
[email protected]

 

SOURCE CloudPost Networks


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: